Mesoblast Limited (MESO)
NASDAQ: MESO · Real-Time Price · USD
11.18
-0.46 (-3.95%)
Nov 19, 2026, 4:00 PM EST - Market closed
Mesoblast Employees
Mesoblast had 108 employees as of June 30, 2026. The number of employees increased by 27 or 33.33% compared to the previous year.
Employees
108
Change (1Y)
27
Growth (1Y)
33.33%
Revenue / Employee
$1,113,426
Profits / Employee
-$532,407
Market Cap
1.47B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 108 | 27 | 33.33% |
| Jun 30, 2025 | 81 | 8 | 10.96% |
| Jun 30, 2024 | 73 | -10 | -12.05% |
| Jun 30, 2023 | 83 | 6 | 7.79% |
| Jun 30, 2022 | 77 | -6 | -7.23% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sarepta Therapeutics | 835 |
| Vir Biotechnology | 367 |
| Nurix Therapeutics | 317 |
| uniQure | 221 |
| Precigen | 160 |
| Absci | 140 |
| AnaptysBio | 104 |
| Nanobiotix | 98 |
MESO News
- 10 hours ago - Mesoblast Wins Deloitte Tech Fast 50 Leadership & Enterprise Growth Award - GlobeNewsWire
- 1 day ago - Mesoblast Transcript: Bell Potter Healthcare Conference - Transcripts
- 2 days ago - Mesoblast Reports US$115M in FY2026 Net Revenue and Outlines Clinical Milestones at ASX Investor Day - Nasdaq
- 3 days ago - Mesoblast Limited Announces Appointment of Jon Voigtman as Director on 10 November 2026 - Nasdaq
- 4 days ago - Mesoblast Showcased at ASX Premier Investor Day Event - GlobeNewsWire
- 4 days ago - Mesoblast Slides: Investor presentation - Filings
- 7 days ago - Mesoblast Limited Announces Leadership Changes and Reports US$115M in FY2026 Net Revenue - Nasdaq
- 8 days ago - Mesoblast Posts $115 Million in Revenue, Sets Sights on 2027 Back Pain Trial Readout - MarketBeat